Amicogen, Inc. (KOSDAQ:092040)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,615.00
+5.00 (0.14%)
Jun 19, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Raw Drug Substance
120.22B
Log In
Log In
Log In
Log In
Upgrade
Raw Drug Substance Growth
12.08%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical
55.18B
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Growth
13.37%
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment
-15.50B
Log In
Log In
Log In
Log In
Upgrade
Consolidated Adjustment Growth
33.09%
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Drugs
-
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Drugs Growth
-
Log In
Log In
Log In
Log In
Upgrade
Product
-
Log In
Log In
Log In
Log In
Upgrade
Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Merchandise
-
Log In
Log In
Log In
Log In
Upgrade
Merchandise Growth
-
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Overseas
132.87B
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
470.63%
Log In
Log In
Log In
Log In
Upgrade
South Korea
27.04B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-77.66%
Log In
Log In
Log In
Log In
Upgrade